Gout and its comorbidities

Michael H Pillinger1, David S Goldfarb, Robert T Keenan

  • 1New York University School of Medicine, NYU Hospital for Joint Diseases, New York, NY 10003, USA. michael.pillinger@nyumc.org

Insights

Gout, a condition of high serum urate (hyperuricemia), often co-occurs with other diseases. This review examines gout comorbidities, exploring causal links and surprising associations with certain neurological conditions.

Area of Science:

  • Rheumatology
  • Nephrology
  • Neurology

Background:

  • Gout is a chronic inflammatory disease caused by hyperuricemia and monosodium urate crystal deposition.
  • Patients with gout frequently present with multiple comorbidities, complicating disease management and prognosis.
  • The relationship between gout/hyperuricemia and comorbidities is complex, involving potential causal or consequential links.

Purpose of the Study:

  • To review significant comorbidities associated with gout and hyperuricemia.
  • To explore the bidirectional relationship between gout/hyperuricemia and these related conditions.
  • To examine neurological conditions where gout or high serum urate may indicate a less severe disease course.

Main Methods:

  • Literature review of studies on gout comorbidities.
  • Analysis of the etiological relationship between gout/hyperuricemia and associated conditions.
  • Investigation of epidemiological data linking serum urate levels to neurological disease outcomes.

Main Results:

  • Gout and hyperuricemia are linked to various comorbidities, including cardiovascular, metabolic, and renal diseases.
  • The review discusses evidence supporting gout as a cause or consequence of certain conditions.
  • An inverse association was noted between gout/high serum urate and some neurological disorders, suggesting a protective effect.

Conclusions:

  • Gout comorbidities significantly impact patient outcomes and require comprehensive management strategies.
  • Understanding the complex interplay between gout, hyperuricemia, and comorbidities is crucial for effective patient care.
  • Further research into the neuroprotective aspects of hyperuricemia may offer novel therapeutic avenues.

Related Concept Videos

Urinary Tract Calculi II: Pathophysiology and Clinical Manifestations01:26

Urinary Tract Calculi II: Pathophysiology and Clinical Manifestations

Renal calculi, commonly termed kidney stones, are crystalline solid masses that form in the kidneys but can occur at any point within the urinary system, encompassing the kidneys, ureters, bladder, and urethra.The pathophysiology of renal stones involves several key factors: supersaturation of the urine with stone-forming constituents, changes in urine pH, a decrease in urine volume, and the presence of substances that promote or inhibit stone formation.Supersaturation of Urine: This is the...
Gastritis III: Clinical Manifestations and Management01:23

Gastritis III: Clinical Manifestations and Management

The clinical manifestations of gastritis can vary depending on the cause and type of gastritis, but some common symptoms may include the following.
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document any history...
Acute Pancreatitis II: Clinical Manifestations and Management01:30

Acute Pancreatitis II: Clinical Manifestations and Management

Acute pancreatitis presents a complex medical emergency characterized by rapid onset inflammation of the pancreas, demanding timely diagnosis and management to prevent complications. The condition primarily manifests through severe upper abdominal pain that often radiates to the back. This pain intensifies following the consumption of fatty foods. Accompanying symptoms such as nausea, vomiting, abdominal distention, fever, dyspnea, cyanosis, and jaundice can vary in intensity but significantly...